Psychoactive drug consumption: Performance-enhancing behaviour and pharmacodependence in workers

Pharmacoepidemiology and Drug Safety

Volumn 14, Issue 2, 2005, Pages 81-89

  Ngoundo Mbongue, T B ^a   Niezborala, M ^b   Sulem, P ^a   Briant Vincens, D ^b   Bancarel, Y ^b   Jansou, P ^b   Chastan, E ^b   Montastruc, J L ^a   Lapeyre Mestre, M ^a  

^a Res Unit of Pharmacoepidemiology   (France)

^b Serv Med Interenterprises Toulouse   (France)

Author keywords

Coping; Performance enhancing behaviour; Pharmacodependence; Psychoactive drug; Workplace

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HYPNOTIC AGENT; NEUROLEPTIC AGENT; OPIATE; PSYCHOTROPIC AGENT;

ADULT; ALCOHOL CONSUMPTION; APTITUDE; ARTICLE; COHORT ANALYSIS; COMPETENCE; CONFIDENCE INTERVAL; COPING BEHAVIOR; DISEASE ASSOCIATION; DRUG ABUSE PATTERN; DRUG DEPENDENCE; DRUG USE; FEMALE; FOLLOW UP; FRANCE; HUMAN; JOB PERFORMANCE; JOB SATISFACTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SLEEP DISORDER; TASK PERFORMANCE; TOBACCO DEPENDENCE; WORK ENVIRONMENT; WORKPLACE;

ADOLESCENT; ADULT; COHORT STUDIES; DRUG UTILIZATION; FEMALE; HUMANS; JOB SATISFACTION; MALE; MIDDLE AGED; PSYCHOTROPIC DRUGS; RISK FACTORS; SOCIOECONOMIC FACTORS; SUBSTANCE-RELATED DISORDERS; WORKPLACE;

EID: 13844281398     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.1006     Document Type: Article

References (36)

1. Alla F, Baumann M. 5 year trajectories for dependence to psychotropics in a cohort of consumers. Therapie 2003; 58(2): 145-151.
2. Legrain M, Lecomte T. The consumption of psychotropics in France and some European countries. Ann Pharm Fr 1998; 56(2): 67-75.
3. Lapeyre-Mestre M, Chastan E, Louis A, Montastruc JL. Drug consumption in workers in France: a comparative study at a 10-year interval (1996 vs 1986). J Clin Epidemiol 1999; 52(5): 471-478.
4. Moisan J, Chabot I, Gregoire J. L'usage des Médicaments Psychotropes Chez les Travailleurs: Prévalence, Déterminants et Conséquences. CPLT-Gouvernement du Québec: Québec, 2000; 49.
5. Ohayon MM, Caulet M, Priest RG, Guilleminault C. Psychotropic medication consumption patterns in the UK general population. J Clin Epidemiol 1998; 51(3): 273-283.
6. Watts D, Short AP. Teacher drug use: a response to occupational stress. J Drug Educ 1990; 20: 47-65.
7. Moisan J, Bourbonnais R, Brisson C, et al. Job strain and psychotropic drug use among white-collar workers. Work Stress 1999; 13: 289-298.
8. Bhattacherjee A, Chau N, Sierra CO, et al. Relationships of job and some individual characteristics to occupational injuries in employed people: a community-based study. J Occup Health 2003; 45(6): 382-391.
9. Dalen P, Beck O, Bergman U, et al. Workplace drug testing (WDT) likely to increase in Europe: report from the First European Symposium on WDT including selected abstracts. Eur J Clin Pharmacol 2000; 56(1): 103-120.
10. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behavior 1983: 385-396.
11. Wanous JP, Reichers AE, Hudy MJ. Overall job satisfaction: how good are single-item measures? J Appl Psychol 1997; 82 2): 247-252.
12. Collaborating Center for Drug Statistics and Methodology. Anatomical Therapeutic Chemical (ATC) Classification Index. WHO: Geneva, 2000.
13. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991; 86(9): 1119-1127.
14. Almudever B, Hajjar V, Damase-Michel C, Lapeyre-Mestre M. Soutiens sociaux et strategies de 'faire face'. Le recours aux psychotropes en situations de chômage et de travail. Cahiers Internationaux de Psychologie Sociale 1997; 33: 21-34.
15. Lapeyre-Mestre M, Sulem P, Niezborala M, et al. Supportive behaviour in working environment: a study in a sample of 2106 workers in the Toulouse metropolitan area. Therapie 2004; (in press).
16. Neutel C. La consommation de substances psychotropes et d'alcool selon le sexe et le revenu familial. Maladies Chroniques au Canada 1992; 13: 44-48.
17. Bourbonnais R, Comeau M, Vezina M. Job strain and evolution of mental health among nurses. J Occup Health Psychol 1999; 4 95-107.
18. Zarifian E. Prescription of psychotropic drugs; use, misuse and abuse. Bull Acad Natl Med 1998; 182(7): 1439-1446; discussion 1446-1447.
19. Storr CL, Trinkoff AM, Anthony JC. Job strain and non-medical drug use. Drug Alcohol Depend 1999; 55(1-2): 45-51.
20. Bongard V, Menard-Tache S, Bagheri H, Kabiri K, Lapeyre-Mestre M, Montastruc JL. Perception of the risk of adverse drug reactions: differences between health professionals and non health professionals. Br J Clin Pharmacol 2002; 54(4): 433-436.
21. Muratet C, Lapeyre-Mestre M, Montastruc J. Study on the regular use of drugs in workers over 50 years of age. Clin Drug Invest 1995; 9: 1-7.
22. Empereur F, Baumann M, Alla F, Briancon S. Factors associated with the consumption of psychotropic drugs in a cohort of men and women aged 50 and over. J Clin Pharm Ther 2003; 28(1): 61-68.
23. Blennow G, Romelsjo A, Leifman H, Leifman A, Karlsson G. Sedatives and hypnotics in Stockholm: social factors and kind of use. Am J Public Health 1994; 84(2): 242-246.
24. Niedhammer I, Lert F, Marne MJ. Psychotropic drug use and shift work among French nurses (1980-1990). Psychol Med 1995; 25 2): 329-338.
25. Cabrita J, Ferreira H, Iglesias P, et al. Study of drug utilization among students at Lisbon University in Portugal. Pharmacoepidemiol Drug Safe 2002; 11: 333-334.
26. Karasek R. Job demands, job decision latitude, and mental strain: implications for job redesign. Adm Sci Q 1979; 24: 285-308.
27. Muntaner C, Anthony JC, Crum RM, Eaton WW. Psychosocial dimensions of work and the risk of drug dependence among adults. Am J Epidemiol 1995; 142(2): 183-190.
28. Cohen D, Mc Cubin M, Collin J, Pérodeau G. Medications as social phenomena. Health 2001; 5(4): 441-469.
29. Baudier F, Orlandini C, Guionet M, Oddoux K. Consommation de tabac des adultes en France: évolution au cours des 10 dernières années. BEH 2000; 48: 1-4.
30. Lejoyeux M, Delaroque F, McLoughlin M, Ades J. Alcohol dependence among elderly French inpatients. Am J Geriatr Psychiatry 2003; 11(3): 360-364.
31. Corcos M, Flament M, Jeammet P. Les Conduites de Dependance: Dimensions Psychopathologiques Communes. Masson ed. Masson: Paris; 2003.
32. Naja WJ, Pelissolo A, Haddad RS, Baddoura R, Baddoura C. A general population survey on patterns of benzodiazepine use and dependence in Lebanon. Acta Psychiatr Scand 2000; 102(6): 429-431.
33. Kan CC, Breteler MH, Zitman FG. High prevalence of benzodiazepine dependence in out-patient users, based on the DSM-III-R and ICD-10 criteria. Acta Psychiatr Scand 1997; 96(2): 85-93.
34. International Narcotics Control Board. Report of the International Narcotics Control Board for 2000 (E/INCB/2000/1). United Nations: New York; 2001.
35. Neutel CI. Risk of traffic accident injury after a prescription for a benzodiazepine. Ann Epidemiol 1995; 5(3 : 239-244.
36. Chipman ML. Risk factors for injury: similarities and differences for traffic crashes and other causes. Accid Anal Prev 1995; 27(5): 699-706.